Markers of early changes in cognition across cohorts of adults with Down syndrome at risk of Alzheimer's disease
Abstract Introduction Down syndrome (DS), a genetic variant of early onset Alzheimer's disease (AD), lacks a suitable outcome measure for prevention trials targeting pre‐dementia stages. Methods We used cognitive test data collected in several longitudinal aging studies internationally from 312...
Main Authors: | Andrew J. Aschenbrenner, R. Asaad Baksh, Bessy Benejam, Jessica A. Beresford‐Webb, Antonia Coppus, Juan Fortea, Benjamin L. Handen, Sigan Hartley, Elizabeth Head, Judith Jaeger, Johannes Levin, Sandra V. Loosli, Anne‐Sophie Rebillat, Silvia Sacco, Frederick A. Schmitt, Kate E. Thurlow, Shahid Zaman, Jason Hassenstab, Andre Strydom |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring |
Subjects: | |
Online Access: | https://doi.org/10.1002/dad2.12184 |
Similar Items
-
The Association between Physical Activity and CAMDEX-DS Changes Prior to the Onset of Alzheimer’s Disease in Down Syndrome
by: Sarah E. Pape, et al.
Published: (2021-04-01) -
The Clinical and Neuropathological Features of Sporadic (Late-Onset) and Genetic Forms of Alzheimer’s Disease
by: Tanzil Rujeedawa, et al.
Published: (2021-10-01) -
Sleep and White Matter in Adults with Down Syndrome
by: Victoria Fleming, et al.
Published: (2021-10-01) -
Neurofilament light chain concentration mediates the association between regional medial temporal lobe structure and memory in adults with Down syndrome
by: Natalie DiProspero, et al.
Published: (2024-01-01) -
Low TGF-β1 plasma levels are associated with cognitive decline in Down syndrome
by: Margherita Grasso, et al.
Published: (2024-03-01)